These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 28760925)

  • 1. The cholesterol ester cycle regulates signalling complexes and synapse damage caused by amyloid-β.
    West E; Osborne C; Bate C
    J Cell Sci; 2017 Sep; 130(18):3050-3059. PubMed ID: 28760925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The phospholipase A
    Osborne C; West E; Bate C
    J Cell Sci; 2018 Apr; 131(8):. PubMed ID: 29588394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breaking the Cycle, Cholesterol Cycling, and Synapse Damage in Response to Amyloid-β.
    Bate C
    J Exp Neurosci; 2017; 11():1179069517733096. PubMed ID: 29238218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monomeric amyloid-β reduced amyloid-β oligomer-induced synapse damage in neuronal cultures.
    Bate C; Williams A
    Neurobiol Dis; 2018 Mar; 111():48-58. PubMed ID: 29272738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glimepiride protects neurons against amyloid-β-induced synapse damage.
    Osborne C; West E; Nolan W; McHale-Owen H; Williams A; Bate C
    Neuropharmacology; 2016 Feb; 101():225-36. PubMed ID: 26432105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An in vitro model for synaptic loss in neurodegenerative diseases suggests a neuroprotective role for valproic acid via inhibition of cPLA2 dependent signalling.
    Williams RS; Bate C
    Neuropharmacology; 2016 Feb; 101():566-75. PubMed ID: 26116815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid-β-induced synapse damage is mediated via cross-linkage of cellular prion proteins.
    Bate C; Williams A
    J Biol Chem; 2011 Nov; 286(44):37955-37963. PubMed ID: 21900234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol ester hydrolase inhibitors reduce the production of synaptotoxic amyloid-β oligomers.
    McHale-Owen H; Bate C
    Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):649-659. PubMed ID: 29247837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid-β(1-40) inhibits amyloid-β(1-42) induced activation of cytoplasmic phospholipase A2 and synapse degeneration.
    Bate C; Williams A
    J Alzheimers Dis; 2010; 21(3):985-93. PubMed ID: 20634578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoacylated Cellular Prion Proteins Reduce Amyloid-β-Induced Activation of Cytoplasmic Phospholipase A2 and Synapse Damage.
    West E; Osborne C; Nolan W; Bate C
    Biology (Basel); 2015 Jun; 4(2):367-82. PubMed ID: 26043272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taxifolin prevents β-amyloid-induced impairments of synaptic formation and deficits of memory via the inhibition of cytosolic phospholipase A
    Wang Y; Wang Q; Bao X; Ding Y; Shentu J; Cui W; Chen X; Wei X; Xu S
    Metab Brain Dis; 2018 Aug; 33(4):1069-1079. PubMed ID: 29542038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clustering of sialylated glycosylphosphatidylinositol anchors mediates PrP-induced activation of cytoplasmic phospholipase A 2 and synapse damage.
    Bate C; Williams A
    Prion; 2012; 6(4):350-3. PubMed ID: 22895089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α-Synuclein-induced synapse damage in cultured neurons is mediated by cholesterol-sensitive activation of cytoplasmic phospholipase A2.
    Bate C; Williams A
    Biomolecules; 2015 Mar; 5(1):178-93. PubMed ID: 25761116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Squalestatin protects neurons and reduces the activation of cytoplasmic phospholipase A2 by Abeta(1-42).
    Bate C; Williams A
    Neuropharmacology; 2007 Aug; 53(2):222-31. PubMed ID: 17583757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytosolic phospholipase A2 mediates neuronal apoptosis induced by soluble oligomers of the amyloid-beta peptide.
    Kriem B; Sponne I; Fifre A; Malaplate-Armand C; Lozac'h-Pillot K; Koziel V; Yen-Potin FT; Bihain B; Oster T; Olivier JL; Pillot T
    FASEB J; 2005 Jan; 19(1):85-7. PubMed ID: 15486059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethanol protects cultured neurons against amyloid-β and α-synuclein-induced synapse damage.
    Bate C; Williams A
    Neuropharmacology; 2011 Dec; 61(8):1406-12. PubMed ID: 21903110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of lipid rafts in the processing of the pathogenic prion and Alzheimer's amyloid-beta proteins.
    Taylor DR; Hooper NM
    Semin Cell Dev Biol; 2007 Oct; 18(5):638-48. PubMed ID: 17822928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicity.
    Falker C; Hartmann A; Guett I; Dohler F; Altmeppen H; Betzel C; Schubert R; Thurm D; Wegwitz F; Joshi P; Verderio C; Krasemann S; Glatzel M
    J Neurochem; 2016 Apr; 137(1):88-100. PubMed ID: 26710111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproic acid and its congener propylisopropylacetic acid reduced the amount of soluble amyloid-β oligomers released from 7PA2 cells.
    Williams RSB; Bate C
    Neuropharmacology; 2018 Jan; 128():54-62. PubMed ID: 28947378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sialylated glycosylphosphatidylinositols suppress the production of toxic amyloid-β oligomers.
    Nolan W; McHale-Owen H; Bate C
    Biochem J; 2017 Aug; 474(17):3045-3058. PubMed ID: 28729427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.